1. Clumeck N, Van Laethem V, Vanhoof R, George R, Rapin M, Butzler JP. Cefotaxime therapy of serious infections with multiresistant Gram-negative bacilli. Scand J Infect Dis 1982; 14: 57.
2. Clumeck N, Van Laethem Y, Gordts B, Jaspar N, Butzler JP. Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms. Antimicrob Agents Chemother 1983; 24: 176.
3. Giamarellou H, Koratzanis G, Kanellakopoulou K, Daikos GK. Epidemiological study of Enterobacter cloacae resistant to 3rd generation cephalosporins: a preliminary report. Chemioterapia 1985; 4: 43.
4. Nani E, Amato G, Lavitola A, Lembo M, Covelli B. Evaluation of ofloxacin activity against recent clinical isolates. J Chemother in press.
5. Lembo M, Pedicini G, Nani E, Covelli B. In vitro antibacterial activity of Norfloxacin against recent clinical isolates. Rass. Med. Sper., 1988; XXXIV: 317–325.